This inventor holds 1 USPTO granted patent. Top assignee: Medicure International, Inc.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Innovative Contributions of Vinh Pham in Cardiovascular Treatment
Introduction
Vinh Pham is an influential inventor based in Winnipeg, Canada, known for his groundbreaking work in the field of pharmaceuticals. With a singular patent to his name, he has made significant strides in developing innovative compounds aimed at addressing critical health challenges related to cardiovascular diseases.
Latest Patents
Vinh Pham holds a patent for "Dual antiplatelet/anticoagulant pyridoxine analogs." This invention relates to compounds designed to exhibit both antiplatelet aggregation and anticoagulant characteristics. These compounds are focused on the treatment of cardiovascular and cerebrovascular diseases and their related symptoms. The methods outlined in his patent involve administering pharmaceutical compositions that include aryl sulfonic pyridoxine and/or substituted pyridoxine analogs, thus offering promising applications in healthcare.
Career Highlights
Currently, Vinh Pham is associated with Medicure International, Inc., a company that is dedicated to developing innovative therapies for critical care and cardiovascular conditions. His role at Medicure has allowed him to contribute significantly to the advancement of medical treatments and to the company’s research portfolio.
Collaborations
Throughout his career, Vinh has worked alongside notable colleagues, including Wasimul Haque and James Diakur. These collaborations have been instrumental in enhancing the scope of his research and broadening the impact of their collective work in medical science.
Conclusion
Vinh Pham’s inventive spirit and dedication to improving medical treatments underscore the importance of innovation in the pharmaceutical industry. His work on dual antiplatelet/anticoagulant pyridoxine analogs presents a promising avenue for the treatment of cardiovascular-related diseases, exemplifying the vital role of inventors in shaping future healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile